Rapid-staged strategy for concomitant critical carotid and left main coronary disease with left ventricular

D E Allie1, M Lirtzman, A P Malik

  • 1Cardiovascular Institute of the South, Columbia Medical Center of Southwest Louisiana, Lafayette 70596-1160, USA. paulr@globalreach.net

Insights

A rapid staged procedure using an intraaortic balloon pump effectively treated high-risk patients with critical carotid and left main coronary disease. This approach reduced complications and hospital stay, offering a safer alternative to traditional staged surgeries.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Concomitant critical carotid artery stenosis and left main coronary artery disease with left ventricular dysfunction presents a high-risk surgical challenge.
  • Traditional simultaneous or staged surgical approaches carry significant risks for this patient group.

Purpose of the Study:

  • To evaluate the safety and efficacy of a rapid staging strategy using an intraaortic balloon pump (IABP) for patients with critical carotid and left main coronary disease.
  • To decrease risks associated with simultaneous or traditional staged surgical interventions.

Main Methods:

  • A cohort of 20 high-risk patients with severe left main coronary artery stenosis (>70%), reduced ejection fraction (<0.30), and severe internal carotid artery stenosis (>90%) were studied.
  • An intraaortic balloon pump was immediately placed before carotid endarterectomy under angiographic guidance.
  • Coronary artery bypass grafting was performed within 24 hours, with IABP removal on the day of surgery (total IABP duration <36 hours).

Main Results:

  • Excellent early outcomes were observed, with 18/20 patients extubated on the day of coronary artery bypass grafting (mean 12 hours).
  • 16/20 patients were discharged from the ICU within 48 hours, with a mean hospital stay of 8 days.
  • No 30-day postoperative deaths, myocardial infarctions, or major neurologic/vascular complications occurred. Long-term follow-up showed sustained patency of operated carotid arteries.

Conclusions:

  • A rapid staged procedure involving angiographically guided IABP placement is safe and effective for high-risk patients with combined carotid and coronary disease.
  • This strategy may reduce operative risks and improve the efficiency and safety of carotid and coronary artery bypass grafting procedures.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...